301688 格林生物
2026/06 - 中期
人民币(K¥)
与去年末期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)

非流动资产
长期股权投资0--000
投资性房地产0--000
固定资产935,7200.06%935,131878,407563,432
在建工程33,1505.93%31,295106,468321,319
无形资产83,833-1.49%85,10488,31385,289
商誉0--000
其他非流动资产19,541-5.40%20,65618,12912,232
1,072,2440.01%1,072,1861,091,317982,271

流动资产
货币资金98,49237.10%71,83854,13222,749
应收账款243,16426.56%192,139173,286143,346
存货411,37514.83%358,236244,883221,746
其他流动资产42,614-48.85%83,30584,17263,767
795,64512.77%705,518556,473451,607

流动负债
短期借款345,23351.71%227,568125,513114,118
应付票据0--00487
应付帐款136,965-12.23%156,044163,780177,663
其他流动负债144,010-7.54%155,760222,283167,765
626,20816.10%539,373511,577460,033
流动资产净值169,4371.98%166,14544,896(8,427)
资产总额减流动负债1,241,6810.27%1,238,3311,136,213973,845

非流动负债
长期借款382,742-20.47%481,276564,052473,712
应付债券0--000
其他非流动负债7,853-6.20%8,3726,0825,172
390,595-20.23%489,648570,134478,884

总权益
    实收股本100,0000.00%100,00056,66756,667
    储备项目751,08615.79%648,683509,413438,294
股东权益851,08613.68%748,683566,079494,961
非控股权益0--000